Hepatitis: Page 2

USPSTF proposes big expansion of hepatitis C screening

The USPSTF gave a B recommendation stating that all adults between the ages of 18 and 79 should undergo screening. Furthermore, the task force advised that screening should be considered for people younger than 18 and older than 79 who are at high risk of infection. The B recommendation means there is high certainty that the net benefit of hepatitis C screening is moderate.

August 27, 2019

USPSTF renews support for routine hepatitis B screening

The statement on hepatitis B gives a grade A recommendation -- meaning the task force has high confidence in the evidence -- for routine screening with the hepatitis B surface antigen (HBsAg) test for all pregnant women. Ideally, testing should be performed in the first trimester, but it should at least be done in an early prenatal visit, according to Stanford University health policy expert Dr. Douglas Owens and colleagues on the task force (JAMA, July 23/30, 2019, Vol. 322:4, pp. 349-354).

July 22, 2019

Abbott's Alinity s gets FDA green light for hepatitis C

The BLA covers the use of hepatitis C virus-encoded antigens for screening individual donors, including volunteer donors, of whole blood and blood components and living donors for the presence of the hepatitis C virus.

July 11, 2019

Most Popular

Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew

In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment

SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience

Roche reports flat diagnostics revenue growth for 2022

French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M

OIG report outlines challenges with CDC-supported COVID-19 vaccination programs